A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change

Health Qual Life Outcomes. 2009 Feb 25:7:17. doi: 10.1186/1477-7525-7-17.

Abstract

Background: To examine the effects of a 6 month lifestyle intervention on quality of life, depression, self-efficacy and eating behavior changes in overweight and obese endometrial cancer survivors.

Methods: Early stage endometrial cancer survivors were randomized to intervention (n = 23) or usual care (n = 22) groups. Chi-square, Student's t-test and repeated measures analysis of variance were used in intent-to-treat analyses. Outcomes were also examined according to weight loss.

Results: Morbidly obese patients had significantly lower self-efficacy, specifically when feeling physical discomfort. There was a significant improvement for self-efficacy related to social pressure (p = .03) and restraint (p = .02) in the LI group. There was a significant difference for emotional well-being quality of life (p = .02), self-efficacy related to negative emotions (p < .01), food availability (p = .03), and physical discomfort (p = .01) in women who lost weight as compared to women who gained weight. Improvement in restraint was also reported in women who lost weight (p < .01).

Conclusion: This pilot lifestyle intervention had no effect on quality of life or depression but did improve self-efficacy and some eating behaviors.

Trial registration: http://www.clinicaltrials.gov; NCT00420979.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Depression / complications
  • Endometrial Neoplasms / complications*
  • Endometrial Neoplasms / psychology
  • Feeding Behavior
  • Female
  • Health Status Indicators
  • Humans
  • Male
  • Obesity / complications
  • Obesity / psychology
  • Obesity / therapy*
  • Pilot Projects
  • Quality of Life* / psychology
  • Risk Reduction Behavior*
  • Self Efficacy
  • Weight Gain
  • Weight Loss

Associated data

  • ClinicalTrials.gov/NCT00420979